Page last updated: 2024-08-21

malondialdehyde and Psychotic Disorders

malondialdehyde has been researched along with Psychotic Disorders in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's0 (0.00)29.6817
2010's5 (50.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Carvalho, AF; Kanchanatawan, B; Maes, M; Sirivichayakul, S1
Bryll, A; Karcz, P; Kozicz, T; Krzyściak, W; Pilecki, M; Popiela, TJ; Skrzypek, J; Śmierciak, N; Szwajca, M1
Ayadi, F; Ben Thabet, J; Charfi, N; Grayaa, S; Guidara, W; Maalej, M; Messedi, M; Naifar, M; Omri, S1
Dhingra, S; Jindal, DK; Parle, M; Yadav, M1
Akyol, O; Kus, I; Ozyurt, B; Ozyurt, H; Sarsilmaz, M; Songur, A1
Acikgoz, HE; Akkaya, C; Dirican, M; Eker, SS; Sarandol, A; Sarandol, E1
Copoglu, US; Dokuyucu, R; Erbas, O; Inanir, A; Inanir, S; Kokacya, H1
Araújo, FY; Carvalho, AF; Gomes, PX; Macêdo, DS; Oliveira, GV; Sousa, FC; Souza, CM; Vasconcelos, SM; Viana, GS1
Gangadhar, BN; Janakiramaiah, N; Pai, BN; Ravindranath, V1
Correnti, EE; Mahadik, JS; Mahadik, SP; Mukherjee, S; Scheffer, R1

Trials

1 trial(s) available for malondialdehyde and Psychotic Disorders

ArticleYear
Elevated plasma lipid peroxides at the onset of nonaffective psychosis.
    Biological psychiatry, 1998, May-01, Volume: 43, Issue:9

    Topics: Adult; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders; Schizoid Personality Disorder; Schizophrenia; Thiobarbituric Acid Reactive Substances

1998

Other Studies

9 other study(ies) available for malondialdehyde and Psychotic Disorders

ArticleYear
In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2020, Volume: 21, Issue:5

    Topics: Humans; Immunoglobulin M; Malondialdehyde; Memory Disorders; Neuropsychological Tests; Psychotic Disorders; Schizophrenia

2020
The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
    Biomolecules, 2020, 09-03, Volume: 10, Issue:9

    Topics: Adult; Antioxidants; Aspartic Acid; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Oxidants; Oxidation-Reduction; Oxidative Stress; Personality Disorders; Prognosis; Psychotic Disorders; Schizophrenia; Young Adult

2020
Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder.
    Psychiatry research, 2020, Volume: 293

    Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Mood Disorders; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; ROC Curve; Schizophrenia; Sensitivity and Specificity; Tunisia

2020
Protective effects of stigmasterol against ketamine-induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:3

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Catalepsy; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutathione; Ketamine; Male; Malondialdehyde; Mice; Motor Activity; Oxidative Stress; Protective Agents; Psychotic Disorders; Stigmasterol; Tumor Necrosis Factor-alpha

2018
Potential role of some oxidant/antioxidant status parameters in prefrontal cortex of rat brain in an experimental psychosis model and the protective effects of melatonin.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:15

    Topics: Animals; Antioxidants; Disease Models, Animal; Dizocilpine Maleate; Glutathione Peroxidase; Male; Malondialdehyde; Melatonin; Oxidants; Oxidative Stress; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Schizophrenia; Superoxide Dismutase

2014
First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.
    Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:11

    Topics: Adult; Antipsychotic Agents; Apolipoprotein B-100; Aryldialkylphosphatase; Bilirubin; Carboxylic Ester Hydrolases; Case-Control Studies; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; Serum Albumin; Serum Albumin, Human; Superoxide Dismutase; Uric Acid; Vitamin E; Young Adult

2015
Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, Dec-08, Volume: 21

    Topics: Acetamides; Animals; Brain; Lipopolysaccharides; Male; Malondialdehyde; Melatonin; Psychotic Disorders; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2015
B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
    Behavioural pharmacology, 2011, Volume: 22, Issue:7

    Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Lipid Peroxidation; Male; Malondialdehyde; Movement Disorders; Oxidative Stress; Psychotic Disorders; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin B Complex

2011
Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration.
    Biological psychiatry, 1994, Oct-01, Volume: 36, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Female; Glutathione; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders

1994